(RTTNews) - Roche (RHHBY) said that the U.S. Food and Drug Administration has granted Emergency Use Authorization for its COVID-19 At-Home Test. It will be available across the United States starting from January.
The test uses a simple anterior nasal swab sample that can be conveniently self-collected and self-tested by individuals aged 14 years and older, and by an adult for children aged 2-13 years old, the company said in a statement.
The company noted that the test is able to produce results in as few as 20 minutes for SARS-CoV-2 and all known variants of concern, including Omicron.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
